Wellgistics shares surge 18.18% premarket after securing exclusive smart contract tech license for PharmacyChain and EinsteinRx platforms.

Wellgistics Health (WGRX) surged 18.18% in premarket trading following the announcement of an exclusive licensing agreement with DataVault AI (DVLT) to integrate digital-ledger smart-contract patents into its PharmacyChain and EinsteinRx platforms. The deal enables Wellgistics to digitize prescription drug tracking using Web 3.0 technology, targeting a $634 billion industry by enhancing transparency, reducing administrative costs, and streamlining rebate processes. Both companies emphasized the strategic value of the partnership, with DataVault CEO Nathaniel Bradley calling it a "revolution" and Wellgistics' interim CEO Prashant Patel aiming to position the firm as a leader in smart contract-enabled pharmaceutical distribution. The move addresses systemic inefficiencies in drug distribution and aligns with broader industry trends toward blockchain-driven solutions.